NCT05576441

Brief Summary

: Interdental papilla deficiency leads to food impaction, problems with phonetics and an unaesthetic appearance. Reconstruction of the deficient papilla is therefore, important. The purpose of study is to compare the VCMX and SCTG in papillae reconstruction. The null hypothesis is that there is no significant difference in clinical outcome for interdental papilla regeneration by volume stable collagen matrix and subepithelial connective tissue graft.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 8, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 12, 2022

Completed
24 days until next milestone

Study Start

First participant enrolled

November 5, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

January 30, 2023

Status Verified

January 1, 2023

Enrollment Period

1.7 years

First QC Date

October 8, 2022

Last Update Submit

January 26, 2023

Conditions

Keywords

Interdental papilla reconstruction

Outcome Measures

Primary Outcomes (1)

  • Gain in papillary height

    distance measured from tip of papilla to an imaginary line connecting most apical point of gingival zenith of adjacent teeth will be measured in mm.

    6 months

Study Arms (2)

test group: VCMX

EXPERIMENTAL

Volume stable collagen matrix will be placed at recipient site and suturing will be done with a 5-0 vicryl suture.

Procedure: volume stable collagen matrix

Control group:SCTG

EXPERIMENTAL

SCTG will be harvested from donor site as per the requirement and will be placed at the recipient and suturing will be done with 5-0 vicryl suture.

Procedure: subepithelial connective tissue graft

Interventions

Volume stable collagen matrix will be placed at recipient site and suturing will be done with a 5-0 vicryl suture.

test group: VCMX

SCTG will be harvested from donor site as per the requirement and will be placed at the recipient and suturing will be done with 5-0 vicryl suture.

Control group:SCTG

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients in the age range of 18-55 years who are systemically healthy.
  • Patients with class II papillary recession according to Norland and Tarnow's classification and radiographically,the distance between contact point(CP) to alveolar crest ≤ 6mm.
  • Patients who have completed etiological periodontal therapy(full mouth scaling and root planning)with Plaque index(Silness and Loe)\<1,gingival index(Loe and silness)\<1 and showing adequate compliance and willing to participate in the study.
  • Patient complains of food lodgement or esthetic consideration for open gingival embrasure

You may not qualify if:

  • Patients with the history of uncontrolled hypertension, diabetes,hyperthyroidism and on medications that influence the outcome of periodontal therapy.
  • Presence of open contacts in the maxillary anterior region.
  • Presence of crowding in the maxillary anterior region.
  • Pregnant and lactating women.
  • Patients with active periodontal disease
  • Smokers,tobacco users

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PGIDS

Rohtak, Haryana, 124001, India

RECRUITING

Study Officials

  • Geetanjali Sharma, BDS

    Post graduate institute of dental sciences,Rohtak

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nishi Tanwar, MDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 8, 2022

First Posted

October 12, 2022

Study Start

November 5, 2022

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

January 30, 2023

Record last verified: 2023-01

Locations